Gain Therapeutics logo

Gain Therapeutics share price today

(GANX)

Gain Therapeutics share price is $1.59 & ₹135.46 as on 25 Dec 2024, 2.30 'hrs' IST

$1.59

0.02

(1.27%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Gain Therapeutics share price in Dollar and Rupees. Guide to invest in Gain Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Gain Therapeutics. Get details on the Indian mutual funds that are investing in Gain Therapeutics. Get Analyst recommendations and forecasts along with all the Gain Therapeutics's financials.

Gain Therapeutics share price movements

  • Today's Low: $1.55
    Today's High: $1.61

    Day's Volatility :4.04%

  • 52 Weeks Low: $0.89
    52 Weeks High: $5.33

    52 Weeks Volatility :83.3%

Gain Therapeutics Returns

PeriodGain Therapeutics IncIndex (Russel 2000)
3 Months
-13.82%
0.0%
6 Months
27.2%
0.0%
1 Year
-42.6%
0.0%
3 Years
-72.15%
-21.1%

Gain Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.57
Open
$1.59
Today's High
$1.61
Today's Low
$1.545
Market Capitalization
$42.2M
Today's Volume
$111.4K
52 Week High
$5.33
52 Week Low
$0.89
Revenue TTM
$0.0
EBITDA
$-21.8M
Earnings Per Share (EPS)
$-1.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-188.83%

How to invest in Gain Therapeutics from India?

It is very easy for Indian residents to invest directly in Gain Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gain Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gain Therapeutics or GANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gain Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gain Therapeutics shares which would translate to 0.536 fractional shares of Gain Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gain Therapeutics, in just a few clicks!

Returns in Gain Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gain Therapeutics investment value today

Current value as on today

₹59,639

Returns

₹40,361

(-40.36%)

Returns from Gain Therapeutics Stock

₹42,599 (-42.6%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Gain Therapeutics

214%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Gain Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 214% more investors are searching Gain Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Gain Therapeutics

  • Gotham Asset Management, LLC

    1.26%

  • Geode Capital Management, LLC

    1.03%

  • Vanguard Group Inc

    0.55%

  • BlackRock Inc

    0.32%

  • JONES FINANCIAL COMPANIES LLLP

    0.20%

  • Renaissance Technologies Corp

    0.20%

Analyst Recommendation on Gain Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gain Therapeutics

What analysts predicted

Upside of 361.21%

Current:

$1.59

Target:

$7.33

Insights on Gain Therapeutics

  • Price Movement

    In the last 1 year, GANX stock has moved down by -40.7%
  • GANX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 67.9%
  • GANX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 97.3%

Gain Therapeutics Technicals Summary

Sell

Neutral

Buy

Gain Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Gain Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gain Therapeutics Inc
-8.09%
27.2%
-42.6%
-72.15%
-85.8%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gain Therapeutics Inc
NA
NA
NA
-0.98
-1.89
-0.73
NA
0.78
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gain Therapeutics Inc
Buy
$42.2M
-85.8%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Gain Therapeutics

gain therapeutics is a preclinical stage biotech company specializing in the discovery of new drugs for orphan diseases. the company targets inborn errors of metabolism; a group of rare diseases of genetic origin with a high unmet medical need. gain therapeutics is also working on a new class of compounds: non-competitive pharmacological chaperones, identified through its innovative proprietary platform – see-tx. the gain therapeutics team is made up of a group of drug discovery and development experts with several decades of experience in biotech and pharma.
Organization
Gain Therapeutics
Employees
29
CEO
Dr. Khalid Islam Ph.D.
Industry
Miscellaneous

Management People of Gain Therapeutics

NameTitle
Dr. Khalid Islam Ph.D.
Executive Chairman
Mr. Gene Mack M.B.A.
CFO & Interim CEO
Dr. Joanne Taylor Ph.D.
Senior Vice President of Research
Dr. Terenzio Ignoni Pharm.D.
Senior Vice President of Technical Operations
Dr. Jonas Hannestad M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in Gain Therapeutics from India :

What is Gain Therapeutics share price today?

Gain Therapeutics share price today stands at $1.59, Open: $1.59 ; Previous Close: $1.57 ; High: $1.61 ; Low: $1.55 ; 52 Week High: $5.33 ; 52 Week Low: $0.89. The stock opens at $1.59, after a previous close of $1.57. The stock reached a daily high of $1.61 and a low of $1.55, with a 52-week high of $5.33 and a 52-week low of $0.89.

Can Indians buy Gain Therapeutics shares?

Yes, Indians can invest in the Gain Therapeutics (GANX) from India.

With INDmoney, you can buy Gain Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gain Therapeutics at zero transaction cost.

How can I buy Gain Therapeutics shares from India?

It is very easy to buy Gain Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gain Therapeutics be purchased?

Yes, you can buy fractional shares of Gain Therapeutics with INDmoney app.

What are the documents required to start investing in Gain Therapeutics stocks?

To start investing in Gain Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gain Therapeutics

Today’s highest price of Gain Therapeutics (GANX) is $1.61.

Today’s lowest price of Gain Therapeutics (GANX) is $1.55.

What is today's market capitalisation of Gain Therapeutics

Today's market capitalisation of Gain Therapeutics GANX is 42.2M

What is the 52 Week High and Low Range of Gain Therapeutics

  • 52 Week High

    $5.33

  • 52 Week Low

    $0.89

What are the historical returns of Gain Therapeutics?

  • 1 Month Returns

    -8.09%

  • 3 Months Returns

    27.2%

  • 1 Year Returns

    -42.6%

  • 5 Years Returns

    -85.8%

Who is the Chief Executive Officer (CEO) of Gain Therapeutics

Dr. Khalid Islam Ph.D. is the current Chief Executive Officer (CEO) of Gain Therapeutics.